바이오테크 보도자료
-
- Bluehole Publishes an Industry Comment on the World's First E&L Testing Laboratory in the Vaping Industry
- China’s leading vaping media, Bluehole New Consumption, today publishes an industry comment on SMOORE‘s establishment of the world’s first E&L testing laboratory in the vaping industry. Here below is the ful...
- 2022년 03월 29일
-
- Takeda’s TAKHZYRO® (lanadelumab) Approved in Japan for Prophylaxis Against Acute Attacks of Hereditary Angioedema (HAE)
- Takeda (TSE:4502/NYSE:TAK) today announced that it has received approval from the Ministry of Health, Labour and Welfare (MHLW) for TAKHZYRO® (lanadelumab) subcutaneous injection 300mg syringes for prophylax...
- 2022년 03월 29일
-
- STALICLA Completes Successful Phase 1b Trials for the First Precision Medicine in Autism Spectrum Disorder
- STALICLA, a Swiss clinical stage biotech company leading omics-based drug development for patients with neurodevelopmental disorders (NDDs), announced today the highly successful completion of the phase 1b t...
- 2022년 03월 28일
-
- Tanner Pharma Increases Europe-Based Inventory of Leukine® to Expand Availability and Enhance Response to Potential Radiation Exposure Due to the Ongoing Conflict in Ukraine
- Tanner Pharma Group, an international distributor of essential medicines, announced that it has significantly increased its inventory of Leukine (sargramostim, yeast-derived rhuGM-CSF) to be held in Europe. ...
- 2022년 03월 25일
-
- ViiV Healthcare announces label update for its long-acting HIV treatment, Cabenuva (cabotegravir, rilpivirine), to be initiated with or without an oral lead-in period
- For media and investors only ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer Inc. and Shionogi Limited as shareholders, today announced that the ...
- 2022년 03월 25일
-
- Publication of provisional end result for Vifor Pharma tender offer: Participation rate of 94 percent
- Regulatory News: This press release features multimedia. View the full release here: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR CSL Behring AG, Berne, Switzerland, a wholly-owned subsidiary of global biotech...
- 2022년 03월 23일
-
- Alchemab Selected to Access NVIDIA Cambridge-1 Supercomputer to Advance Machine Learning Enabled Antibody Discovery
- Alchemab Therapeutics, a biotechnology company focused on the discovery and development of naturally-occurring protective antibodies and immune repertoire-based patient stratification tools, has been selecte...
- 2022년 03월 23일
-
- In a World First, Yokogawa and JSR Use AI to Autonomously Control a Chemical Plant for 35 Consecutive Days
- Yokogawa Electric Corporation (TOKYO: 6841) and JSR Corporation (JSR, TOKYO: 4185) announce the successful conclusion of a field test in which AI was used to autonomously run a chemical plant for 35 days, a ...
- 2022년 03월 22일
-
- More Than Half of Physicians Have Been Asked By Patients for an Unapproved COVID-19 Treatment
- A new survey from Sermo, a physician-first online community and leader in global HCP insights, found that physicians are facing a challenging onslaught of COVID-19 vaccine and treatment misinformation as rep...
- 2022년 03월 17일
전시회
